Diality News and Clinical Updates

IRVINE, Calif.--(BUSINESS WIRE)--Diality Inc., a medical device company responsible for the development of the Moda-flx™ Hemodialysis System, has announced a panel discussion entitled “Expanding Choice in Hemodialysis” to be held on Friday, October 23 during the American Society of Nephrology’s Kidney Week 2026 in Denver. Expert panelists will discuss clinical evidence pertaining to hemodiafiltration (HDF) and perspectives for successful integration into kidney care in the United States

IRVINE, Calif.--(BUSINESS WIRE)--Diality Inc., a medical device company that has developed the Moda-flx™ Hemodialysis System, today announced it has named Peter Donato as its chief financial officer. Donato joins the company as it continues to enroll patients in the PRESCRIBE Diality Home Hemodialysis Clinical Trial of its Moda-flx Hemodialysis System

IRVINE, Calif.--(BUSINESS WIRE)--Diality Inc. today announced that three posters highlighting new data from the first clinical use of the Moda-flx™ Hemodialysis System will be presented during the American Society of Nephrology’s Kidney Week 2025 in Houston, Texas.

IRVINE, Calif.--(BUSINESSWIRE)-- Diality Inc., a medical device company that has developed the Moda-flx™ Hemodialysis System, today announced the first patient treatment in its PRESCRIBE Diality Home Hemodialysis Clinical Trial in partnership with aQua Research Institute and aQua Dialysis in Houston, Texas. Diality is conducting the PRESCRIBE Diality trial under an Investigational Device Exemption (IDE) to evaluate a home use indication for the Moda-flx Hemodialysis System. The Moda-flx Hemodialysis System received U.S. Food and Drug Administration (FDA) clearance for use in professional care settings in August 2024.

IRVINE, Calif.--(BUSINESS WIRE)--Diality, a medical device company that has developed the Moda-flx Hemodialysis System™, today announced the addition of Dr. Chris Springer to its board of directors.

IRVINE, Calif.--(BUSINESS WIRE)--Diality, a medical device company developing a smart, flexible hemodialysis platform, today announced successful completion of the first-ever patient treatment with the Moda-flx Hemodialysis System™ in collaboration with North America Research Institute at Ontario-Holt Dialysis Center in Ontario, Calif.

IRVINE, Calif.--(BUSINESS WIRE)--Diality, a medical device company offering the Moda-flx Hemodialysis System™, today announced that it has joined Kidney Care Partners, the nation’s leading kidney care multi-stakeholder coalition representing patient advocates, physician organizations, health professional groups, dialysis providers, researchers, and manufacturers.

Diality, a medical device company developing a smart, flexible hemodialysis platform, today announced that it has secured 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its Moda-flx Hemodialysis System™.